For years, Ambry has been offering educational webinars to our employees as a way to make sure genetic counselors across multiple functions within the company were always up to date on the latest research. Now, we are opening up this program to all genetics professionals, in the form of a new program called EducateNext. This program will present…
There has been a lot of talk about Direct-To-Consumer (DTC) genetic testing and the caveats that come along with that type of testing, but what does it all really mean? What is the actual difference between a DTC genetic test and a genetic test ordered by a medical professional through a clinical laboratory? There are several things that make…
The explosion of direct-to-consumer genetic testing over the last few years has created a ton of buzz, beyond just ancestry, health traits and wine preferences. Many of these DTC labs also release raw data to the consumer; this often leaves many individuals interested in what these findings mean and their potential impact on their healthcare management.…
There are many factors that impact your patients’ risk to develop certain cancers, including whether or not they have a family history of the disease, which can significantly impact the likelihood they may develop cancers such as breast, colorectal, and prostate. Individuals with a strong family history of cancer may have a hereditary cancer…
From consumers, to physicians to genetic counselors, the importance of heart health is taking center stage in genetics. Clinicians from all specialties are recognizing the benefits of cardiovascular genetic testing; inherited arrhythmias, cardiomyopathies, thoracic aortic aneurysms, and familial hypercholesterolemia are becoming more commonly discussed…
Ambry Celebrates a Milestone Year Ambry is looking forward to an exciting 2018, after experiencing a year of reaching important milestones and seeing many changes in 2017. From joining the Konica Minolta family, to the launch of our paired testing in our mission to understand all disease, to say it was a busy year is an understatement. Test Launches…
At Ambry, “Finding Answers” is at the core of what we do. We know patients and clinicians depend on us to find answers that help them better understand diseases, and improve outcomes. 2017 has been a busy and productive year for Ambry. In particular, using Ambry’s clinical exome test, ExomeNext, we have been successful in identifying…
It has been an exciting and busy year at Ambry Genetics, packed with steps forward on our path towards understanding all human disease. We have continued our dedication, not only to quality testing, but to innovation, research, and patient advocacy. As we reach the end of 2017, we look forward to an even more impactful 2018 and working together…
I have been a genetic counselor for nearly 20 years and in that time, I have worked with everything from prenatal to adult genetics. No matter which discipline I was working in, family history was always my number one tool. Everybody’s personal and family history can hold clues to the types of diseases for which they may be at risk. Therefore,…
Precision medicine is an emerging healthcare model built on the idea that drugs designed to target precise genetic causes of diseases will be cheaper, safer and most importantly, more effective for patients with a mutation. Although precision medicine applies to all therapeutic areas, the rapid progress in identifying new epilepsy genes represents…